首页 | 本学科首页   官方微博 | 高级检索  
检索        

高聚生与顺铂治疗恶性胸水疗效对比分析(附35例临床报告)
引用本文:刘永欣,常锦秋,李咏梅.高聚生与顺铂治疗恶性胸水疗效对比分析(附35例临床报告)[J].沈阳医学院学报,2004,6(1):9-9,13.
作者姓名:刘永欣  常锦秋  李咏梅
作者单位:沈阳医学院附属中心医院心胸外科,辽宁,沈阳,110024
摘    要:目的:研究高聚生与顺铂治疗恶性胸水的疗效比较。方法:选择35例患有恶性胸水的住院患者,分别胸腔内注射高聚生与顺铂。结果:应用HAS疗效为83.3%,应用DDP疗效为58.8%。结论:高聚生治疗恶性胸水疗效优于顺铂,效果确切,无明显毒副作用。

关 键 词:高聚生  顺铂  治疗  恶性胸水  胸腔内注射  恶性肿瘤
文章编号:1008-2344(2004)01-0009-01
修稿时间:2003年10月15

The Comparative Analysis of Curative Effect of HAS and DDP Treating Malignant Pleural Effusion( 35 example clinical reports )
LIU Yong xin,CHANG Jin qiu,LI Yong mei.The Comparative Analysis of Curative Effect of HAS and DDP Treating Malignant Pleural Effusion( 35 example clinical reports )[J].Journal of Shenyang Medical College,2004,6(1):9-9,13.
Authors:LIU Yong xin  CHANG Jin qiu  LI Yong mei
Abstract:Objective: To compare the curative effect of HAS and DDP treating malignant pleural effusion. Methods: Patients in hospital suffering from malignant pleural effusion were selected and injected intrapleural with HAS and DDP individually. Results: HAS curative effect of treating malignant pleural effusion is superior to DDP. Conclusion: The result of treating malignant pleural effusion with HAS is exact. No obvious toxicity or side effects was observed.
Keywords:HAS  DDP  malignant pleural effusion
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号